Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.24+0.22 (+0.31%)
Close on Nov 18, 2026Market cap $230.00MP/E 22.0Yield –
Utah Medical Products operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Utah Medical Products's operating income for the twelve months ending Jun 30, 2026 was $10.27M. For fiscal 2025 it was $11.40M, down 16.1% from the year before. Over ten years it grew -3.1% a year on average. The highest annual figure on record is $19.79M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.40M | -16.1% |
| FY2024 | Dec 31, 2024 | $13.59M | -19.0% |
| FY2023 | Dec 31, 2023 | $16.78M | -15.2% |
| FY2022 | Dec 31, 2022 | $19.79M | +4.8% |
| FY2021 | Dec 31, 2021 | $18.88M | +37.7% |
| FY2020 | Dec 31, 2020 | $13.71M | -22.3% |
| FY2019 | Dec 31, 2019 | $17.63M | -5.7% |
| FY2018 | Dec 31, 2018 | $18.70M | -1.7% |
| FY2017 | Dec 31, 2017 | $19.01M | +17.4% |
| FY2016 | Dec 31, 2016 | $16.19M | +3.4% |
| FY2015 | Dec 31, 2015 | $15.65M | -3.4% |
| FY2014 | Dec 31, 2014 | $16.20M | +9.3% |
| FY2013 | Dec 31, 2013 | $14.83M | -2.4% |
| FY2012 | Dec 31, 2012 | $15.20M | +28.3% |
| FY2011 | Dec 31, 2011 | $11.84M | +32.7% |
| FY2010 | Dec 31, 2010 | $8.92M | -5.4% |
| FY2009 | Dec 31, 2009 | $9.43M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.65M | -17.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.57M | -18.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.44M | -38.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.61M | -34.2% |
| Q2 FY2025 | Jun 30, 2025 | $3.20M | -27.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.15M | -29.0% |
| Q4 FY2023 | Dec 31, 2023 | $3.94M | -22.2% |
| Q3 FY2023 | Sep 30, 2023 | $3.97M | -22.8% |
| Q2 FY2023 | Jun 30, 2023 | $4.43M | -12.5% |
| Q1 FY2023 | Mar 31, 2023 | $4.44M | -1.8% |
| Q4 FY2022 | Dec 31, 2022 | $5.07M | -1.2% |
| Q3 FY2022 | Sep 30, 2022 | $5.14M | +0.8% |
| Q2 FY2022 | Jun 30, 2022 | $5.06M | +6.1% |
| Q1 FY2022 | Mar 31, 2022 | $4.52M | +16.3% |
| Q4 FY2021 | Dec 31, 2021 | $5.13M | +19.9% |
| Q3 FY2021 | Sep 30, 2021 | $5.10M | +42.1% |
| Q2 FY2021 | Jun 30, 2021 | $4.77M | +141.0% |
| Q1 FY2021 | Mar 31, 2021 | $3.89M | +0.6% |
| Q4 FY2020 | Dec 31, 2020 | $4.28M | -8.5% |
| Q3 FY2020 | Sep 30, 2020 | $3.59M | -17.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.98M | -55.9% |
| Q1 FY2020 | Mar 31, 2020 | $3.86M | -5.8% |
| Q4 FY2019 | Dec 31, 2019 | $4.68M | +9.6% |
| Q3 FY2019 | Sep 30, 2019 | $4.37M | -0.7% |
| Q2 FY2019 | Jun 30, 2019 | $4.48M | -11.4% |
| Q1 FY2019 | Mar 31, 2019 | $4.10M | -17.5% |
| Q4 FY2018 | Dec 31, 2018 | $4.27M | -6.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.40M | -5.9% |
| Q2 FY2018 | Jun 30, 2018 | $5.06M | +0.4% |
| Q1 FY2018 | Mar 31, 2018 | $4.97M | +5.2% |
| Q4 FY2017 | Dec 31, 2017 | $4.57M | +26.3% |
| Q3 FY2017 | Sep 30, 2017 | $4.68M | +18.8% |
| Q2 FY2017 | Jun 30, 2017 | $5.03M | +16.7% |
| Q1 FY2017 | Mar 31, 2017 | $4.73M | +9.6% |
| Q4 FY2016 | Dec 31, 2016 | $3.62M | -4.9% |
| Q3 FY2016 | Sep 30, 2016 | $3.94M | – |
| Q2 FY2016 | Jun 30, 2016 | $4.32M | – |
| Q1 FY2016 | Mar 31, 2016 | $4.31M | – |
| Q4 FY2015 | Dec 31, 2015 | $3.81M | – |
See a number that looks wrong?